(Adds Outlook)
For the full year, Pharming Group N.V. (PHAR) expects revenue of $280 million to $295 million, a 14 percent to 20 percent growth.
Pharming reported Loss for fourth quarter that decreased from the same period last year
The company's bottom line came in at -$2.7 million, or -$0.004 per share. This compares with -$14.6 million, or -$0.022 per share, in last year's fourth quarter.
The company's revenue for the quarter rose 48.7% to $81.2 million from $54.6 million last year.
Pharming Group N.V. earnings at a glance (GAAP) :
-Earnings (Q4): -$2.7 Mln. vs. -$14.6 Mln. last year.
-EPS (Q4): -$0.004 vs. -$0.022 last year.
-Revenue (Q4): $81.2 Mln vs. $54.6 Mln last year.
For comments and feedback: editorial@rttnews.com